Borderless MedDev helps medical-device innovators develop clear regulatory strategies, navigate FDA submissions, resolve compliance challenges, and build quality systems that support successful commercialization. We partner with startups and small-to-midsize medical-device manufacturers preparing for market entry, responding to FDA feedback, or strengthening their quality operations. Clients work directly with seasoned regulatory and quality experts, without junior-staff handoffs. Our capabilities include: • FDA regulatory strategy • Pre-Submission meetings and Q-Sub packages • 510(k), De Novo, and eSTAR submission preparation • FDA Additional Information response support • Stalled or unsuccessful submission remediation • FDA QMSR and ISO 13485 implementation • MDSAP and international quality-system support • Post-market compliance, complaints, and CAPA • Internal and supplier quality audits • Design controls, human factors, and verification and validation • IEC 60601-1 and medical-device safety consulting • Fractional quality leadership and team training Our team brings decades of medical-device experience spanning regulatory affairs, quality systems, product development, testing, and global commercialization. We work directly with regulators, testing partners, and client teams to turn complex requirements into practical plans. Whether you are preparing a submission, responding to an FDA request, remediating a quality issue, or developing a scalable QMS, Borderless MedDev can help clarify your path forward. Visit www.borderlessmd.com/contact-us to discuss your regulatory or quality challenge.
Looking for a particular Borderless MedDev employee's phone or email?
Scott Blomberg is the Founder and Chief Scientific Officer of Borderless MedDev.
3 people are employed at Borderless MedDev.
Borderless MedDev is based in Maple Grove, Minnesota.